Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadrivalent Split-Virion Inactivated Influenza Vaccine in Adults ≥60 Years
CTR20190846Phase 3Active
- Sponsor
- Wuhan Institute of Biological Products
- Start
- May 2019
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of influenza virus quadrivalent inactivated vaccine in influenza, sponsored by Wuhan Institute of Biological Products. Started May 2019; status: active.
02
Drugs
influenza virus quadrivalent inactivated vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20190846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190846.